Titlebook: Novel Antischizophrenia Treatments; Mark A. Geyer,Gerhard Gross Book 2012 Springer-Verlag Berlin Heidelberg 2012 Cognition.Neurotransmitte

Ingrown-Toenail

書目名稱Novel Antischizophrenia Treatments影響因子(影響力)




書目名稱Novel Antischizophrenia Treatments影響因子(影響力)學(xué)科排名




書目名稱Novel Antischizophrenia Treatments網(wǎng)絡(luò)公開度




書目名稱Novel Antischizophrenia Treatments網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Novel Antischizophrenia Treatments被引頻次




書目名稱Novel Antischizophrenia Treatments被引頻次學(xué)科排名




書目名稱Novel Antischizophrenia Treatments年度引用




書目名稱Novel Antischizophrenia Treatments年度引用學(xué)科排名




書目名稱Novel Antischizophrenia Treatments讀者反饋




書目名稱Novel Antischizophrenia Treatments讀者反饋學(xué)科排名

友好關(guān)系

Clinical Instruments to Evaluate and Guide Treatment in Schizophrenia,ces. This has led to the use of functional capacity measures which monitor an individual’s ability to perform functionally meaningful tasks even if they do not complete these tasks. Attention has also focused on interview-based measures of cognition and negative symptoms. Both of these psychopatholo

Hdl348

DIKE

fidelity

Towards Medication-Enhancement of Cognitive Interventions in Schizophrenia, might be possible to significantly enhance the efficacy of cognitive therapies. We review and suggest several laboratory measures that might detect potential pro-neurocognitive effects of drugs in individual patients, using a “test dose” design, aided by specific biomarkers predicting an individual

Comprise

Mutant Mouse Models in Evaluating Novel Approaches to Antipsychotic Treatment,enetics of schizophrenia and mutant models relating to replicable risk genes. Lastly, we extend this discussion by exemplifying two new variant approaches in mutant mice that may serve as prototypes for advancing antipsychotic drug development. There is continuing need not only to address numerous t

類似思想

節(jié)約

The Role of Dopamine D3 Receptors in Antipsychotic Activity and Cognitive Functions,iating positive symptoms is still unsettled, selective D. receptor antagonism has therapeutic features for schizophrenia and beyond as demonstrated by several animal models: improved cognitive function, emotional processing, executive function, flexibility, and social behavior. D. receptor antagonis

Ornithologist

collagenase